So why have we seen large grants for drugs with little to no prospect of succeeding? What other drug brings so many benefits to the table as Brilacidin? What other drug is being asked by an RBL to be investigated for a PAN-CORONA?
Why wouldn't one expect a large grant award? Not only are they looking at CV19, they want to look at ALL Corona viruses in addition to many more + areas of inflammation (kidney, brain, lung, etc)
Market Data 
Markets 
